Arbutus Biopharma Stock (NASDAQ:ABUS), Insider Trading Activity

Arbutus Biopharma: Insider buying and selling updated today.

Insider Shares Owned

6.728M

Insider Percentage Owned

4.01%

Institutional Shares Held

31.422M

Institutional Percentage Held

17.4%

Filing Date ▲▼	Insider Names ▲▼	Insider Title ▲▼	Qty. ▲▼	Price ▲▼	Size ($) ▲▼	Type ▲▼	Δ Own ▲▼	Own ▲▼	Trade Dates ▲▼	SEC Filing ▲▼
Feb 05, 2024	Karen Sims	CHIEF MEDICAL OFFICER	96.642K	$2.31	-$10.08K	GRANT	334.40%	125.542K	Feb 01 - Feb 02	View
Feb 05, 2024	David C Hastings	CHIEF FINANCIAL OFFICER	102.907K	$2.31	-$22.18K	GRANT	130.26%	181.907K	Feb 01 - Feb 02	View
Feb 05, 2024	Michael J Sofia	CHIEF SCIENTIFIC OFFICER	99.518K	$2.31	-$23.08K	GRANT	6.41%	1.652283M	Feb 01 - Feb 02	View
Feb 05, 2024	Michael J McElhaugh	INTERIM PRESIDENT & CEO	113.636K	$2.31	-$23.50K	GRANT	8.17%	1.504793M	Feb 01 - Feb 02	View
Dec 03, 2021	Michael J Sofia	CHIEF SCIENTIFIC OFFICER	-200K	$5.09	-$1.02M	SELL	-11.97%	1.470565M	Dec 01	View
Feb 10, 2021	Michael J McElhaugh	CHIEF BUSINESS OFFICER	-20K	$5.00	-$100.00K	SELL	-1.51%	1.307457M	Feb 09	View
Dec 16, 2020	Michael J McElhaugh		-40K	$5.00	-$200.03K	SELL	-2.93%	1.327457M	Dec 14	View
Jul 27, 2020	Michael J McElhaugh		-20K	$5.01	-$100.20K	SELL	-1.44%	1.367457M	Jul 23	View

FAQ

Is Insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

ABUS Insider Trading News

No news found